References
Oraby MI, Srie MA, Abdelshafy S, Elfar E. Diabetic peripheral neuropathy: the potential role of vitamin D deficiency. Egypt J Neurol Psychiatry Neurosurg. 2019;55:10.
Roglic G, World Health Organization, editors. Global report on diabetes. Geneva: World Health Organization; 2016.
Bartoli E, Sainaghi PP, Bergamasco L, Castello L. Hyperosmolar coma due to exclusive glucose accumulation: recognition and computations. Nephrol Carlton Vic. 2009;14:338–44.
Bartoli E, Sainaghi PP, Bergamasco L, Castello L. Computation of the excess glucose and Na deficit of hypo-osmolar hyponatremic hyperglycaemia. Acta Diabetol. 2010;47:147–54.
Tesfaye S, Boulton AJM, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–93.
Abdelsadek SE, El Saghier EO, Abdel Raheem SI. Serum 25(OH) vitamin D level and its relation to diabetic peripheral neuropathy in Egyptian patients with type 2 diabetes mellitus. Egypt J Neurol Psychiatry Neurosurg. 2018;54:36.
Bellan M, Sainaghi PP, Pirisi M. Role of vitamin D in rheumatoid arthritis. Adv Exp Med Biol. 2017;996:155–68.
Bellan M, Pirisi M, Sainaghi PP. Osteoporosis in rheumatoid arthritis: role of the vitamin D/parathyroid hormone system. Rev Bras Reumatol. 2015;55:256–63.